Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma.

Suzanne J. Forrest, J. Andrew Livingston, Kieuhoa Tran Vo, Julia Lynne Glade Bender, Amy Opara, Simon Smith, Neel Shah, Nan Chen, Wendy B London, E. Alejandro Sweet-Cordero, Katherine A. Janeway